EAEty Apriliana

Ety Apriliana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ety Apriliana has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploration and Biorefinery Antimicrobial Agent through Solid State Fermentation from Indonesia’s Marine Actinomycetes

    by Aspita Laila, Fendi Setiawan, Widyastuti Widyastuti, Muhammad Rizky Fadhilah, Andi Setiawan, Ni Luh Gede Ratna Juliasih, Wawan Abdullah Setiawan, Ety Apriliana, Peni Ahmadi, Masayoshi Arai, et al.

    This study aimed to obtain novel bioactive compounds derived from actinomycetes associated with marine biota from the coast of Indonesia. Actinomycetes have been identified as a potential source of bioactive compounds through enzymatic fermentation. In order to obtain bioactive compounds from the results of the biorefinery process, cultivation was performed by solid state fermentation (SSF) on shrimp shell waste medium. The inhibitory activity against pathogenic microorganisms was measured based on the optical density of samples from Gorontalo and Buleleng, Bali, Indonesia. Six isolates had a clear zone as an indicator of the chitinase activity of chitinase enzymes. The SSF extract, obtained after 14 days of incubation, was assayed for its antimicrobial activity by the 96-well plate microtiter method. Among the six isolates, isolate 19B19A1 had antibacterial and antifungal activity against Staphylococcus aureus and Malassezia globosa, respectively. DNA analysis indicated that the 19B19A1 isolate was Streptomyces tritolerans 19B19A1 and that its extract contained an alkaloid component that played a role in antimicrobial activity. These results indicate that shrimp shells can be used as a nutrient-rich alternative culture medium for actinomycetes. This study is expected to become a source of information related to biorefinery, especially in the exploration of bioactive compounds produced by actinomycetes.


  • Open Access

    Efek Pemberian Ekstrak Temulawak (Curcuma Xanthorrhiza Roxb) terhadap Daya Hambat Pertumbuhan Staphylococcus Aureus dan Escherichia Coli secara In Vitro

    by Alexander Dicky, Ety Apriliana

    Prevalensi penyakit infeksi di Indonesia masih tergolong tinggi dan menjadi masalah kesehatan di Indonesia. Salah satu penyebab penyakit infeksi adalah bakteri. Antibiotik adalah terapi yang digunakan untuk melawan bakteri. Ekstrak etanol temulawak (Curcuma xanthorrhiza Roxb) memiliki berbagai manfaat, salah satunya sebagai antimikroba karena kandungan kurkumin dan minyak atsiri dalam temulawak dapat menghambat dan membunuh pertumbuhan bakteri. Penelitian inibertujuan untuk mengetahui efek pemberian ekstrak etanol temulawak terhadap daya hambat pertumbuhan Staphylococcus aureus dan Escherichia coli secara in vitro. Dengan menggunakan metode kirby bauer disk diffusion, ekstrak etanol temulawak dengan konsentrasi 10%, 15%, 20%, 25%, 30%, 40%, 80%, 100%, kontrol negatif (akuades steril)dan kontrol positif (kloramfenikol) ditanam dalam Muller Hinton Agar berisi bakteri, diinkubasi dan diukur zona hambat yang terbentuk. Berdasarkan hasil penelitian diketahui bahwa ekstrak etanol temulawak (Curcuma xanthorrhiza Roxb) memiliki daya hambat terhadap bakteri Staphylococcus aureus dan Escherichia coli pada semua konsentrasi uji. [JK Unila. 2016; 1(2)]Kata kunci: antibakteri, Curcuma, daya hambat, Escherichia coli, Staphylococcus aureus